PepGen Aktie - PEPG

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

4,51

Gebot

3,54

Fragen

5,25

Volumen

454.825

2,90 Tagesbereich 4,71

4,00 52-Wochen-Bereich 19,298

Marktkapitalisierung

147,007M

Handelsende

4,68

Handelsbeginn

2,90

Letzte Trade

4.66

Letzter Handelszeitpunkt

Finanzvolumen

US$ 1.754.212

VWAP

3,8569

Durchschnittliches Volumen (3 Mio.)

136.232

Ausgegebene Aktien

32.595.737

Dividendenrendite

Kurs-Gewinn-Verhältnis

-1,88

Gewinn pro Aktie (EPS)

-2,41

Erlöse

Nettogewinn

-78,63M

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

pepgen.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

PepGen Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PEPG. The last closing price for PepGen was US$4,68. Over the last year, PepGen shares have traded in a share price range of US$ 4,00 to US$ 19,298.

PepGen currently has 32.595.737 shares in issue. The market capitalisation of PepGen is US$152,55 million. PepGen has a price to earnings ratio (PE ratio) of -1.88.

Form 8-K - Current report

PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy

-Company continues to advance PGN-EDO51 in CONNECT1-EDO51, with the 10 mg/kg cohort now fully enrolled- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next...

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-1.14	-20.1769911504	5.65	6.09	4.54	390678	4.80148275	CS
4	0.31	7.38095238095	4.2	6.85	4	192712	5.11645701	CS
12	-4.82	-51.6613076099	9.33	9.935	4	136232	5.92750205	CS
26	-12.49	-73.4705882353	17	19.298	4	143851	9.09061654	CS
52	-2.11	-31.8731117825	6.62	19.298	4	121317	10.65475995	CS
156	-11.09	-71.0897435897	15.6	20	3.72	109562	10.76097711	CS
260	-11.09	-71.0897435897	15.6	20	3.72	109562	10.76097711	CS

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
SIDUSidus Space Inc	US$ 4,5657 (219,28%)	296,9M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0,5179 (115,34%)	1,2B
OPTXSyntec Optics Holdings Inc	US$ 1,79 (81,62%)	15,84M
QUBTQuantum Computing Inc	US$ 11,075 (65,18%)	114,58M
INVZWInnoviz Technologies Ltd	US$ 0,172 (56,22%)	167,63k
SOBRSOBR Safe Inc	US$ 1,15 (-67,79%)	5,58M
ZCARZoomcar Holdings Inc	US$ 1,6804 (-67,56%)	3,09M
AKTSAkoustis Technologies Inc	US$ 0,0411 (-39,74%)	53,76M
RDZNRoadzen Inc	US$ 1,23 (-30,90%)	2,5M
GLEGlobal Engine Group Holding Ltd	US$ 1,70 (-30,89%)	267,58k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0,5179 (115,34%)	1,19B
WBUYWeBuy Global Ltd	US$ 0,215352 (22,64%)	530,08M
SIDUSidus Space Inc	US$ 4,5657 (219,28%)	296,29M
NVDANVIDIA Corporation	US$ 132,00 (-1,68%)	234,71M
RGTIRigetti Computing Inc	US$ 8,41 (17,46%)	227,81M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

PepGen Inc (PEPG) Börsenkurse

PepGen Inc (PEPG)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über PepGen Inc

PEPG Neueste Nachrichten

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen